CrannMed has been awarded €3.5m via the highly competitive EU funded Horizon EIC Accelerator project instrument. This 2-year project will fund a pivotal clinical trial, CE Mark approval and FDA clearance in preparation for commercialisation of its EmboSure device for the treatment of knee osteoarthritis.

EIC announces new wave of start-up champions (